Monocarboxylic acid transporter 1 (SLC16A1) Rabbit Polyclonal Antibody
CAT#: TA321555
Anti-SLC16A1 Rabbit Polyclonal Antibody
Size: 25 ul
Need it in bulk or conjugated?
Get a free quote
CNY 1,999.00
CNY 3,280.00
Cited in 3 publications. |
CNY 3,080.00
CNY 300.00
CNY 1,430.00
CNY 2,900.00
CNY 6,650.00
CNY 9,998.00
Specifications
Product Data | |
Applications | IHC, WB |
Recommend Dilution | WB: 500-2000 WB positive control: Jurkat cell lysate IHC: 50-100 Positive control: Human ovarian cancer Predicted cell location: Cytoplasm and Cell membrane |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | Synthetic peptide corresponding to a region derived from 484-500 amino acids of Human solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
Formulation | PBS pH7.3, 0.05% NaN3, 50% glycerol |
Concentration | lot specific |
Purification | Antigen affinity purification |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 54 kDa |
Gene Name | solute carrier family 16 member 1 |
Database Link | |
Background | The protein encoded by this gene is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates; such as lactate and pyruvate; across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. Alternatively spliced transcript variants have been found for this gene. |
Synonyms | HHF7; MCT; MCT1; MCT1D |
Reference Data | |
Protein Families | Transmembrane |
Citations (3)
The use of this Antibodies has been cited in the following citations: |
---|
Cyclosporine protects from intestinal epithelial injury by modulating butyrate uptake via upregulation of membrane monocarboxylate transporter 1 levels
,Ota, S;Sakuraba, H;Hiraga, H;Yoshida, S;Satake, M;Akemoto, Y;Tanaka, N;Watanabe, R;Takato, M;Murai, Y;Ueno, K;Niioka, T;Hayakari, M;Ishiguro, Y;Fukuda, S;,
Biochem Biophys Rep
,PubMed ID 33102812
[SLC16A1]
|
Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment
,Nelson, GL;Ronayne, CT;Solano, LN;Jonnalagadda, SK;Jonnalagadda, S;Rumbley, J;Holy, J;Rose-Hellekant, T;Drewes, LR;Mereddy, VR;,
Sci Rep
,PubMed ID 31797891
[SLC16A1]
|
A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma
,Khammanivong, A;Saha, J;Spartz, AK;Sorenson, BS;Bush, AG;Korpela, DM;Gopalakrishnan, R;Jonnalagadda, S;Mereddy, VR;O'Brien, TD;Drewes, LR;Dickerson, EB;,
Vet Comp Oncol
,PubMed ID 31661586
[SLC16A1]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
其它Monocarboxylic acid transporter 1产品